Simone Meijer
Guest employee
- Name
- S. Meijer
- Telephone
- +31 71 527 2727
- s.meijer@fsw.leidenuniv.nl
- ORCID iD
- 0000-0003-0152-567X
Research
My PhD research is part of a VICI project focusing on the role of nocebo effects in the sensitization and desensitization of insufficiently explained somatic symptoms, such as pain, itch or fatigue. In this project, the influence of negative expectations on the onset, course, and recovery of these symptoms will be investigated. These symptoms have a great impact on daily functioning of patients, and effective treatments are limited. The aim of my project is to develop an effective treatment for the desensitization of persistent insufficiently explained somatic symptoms, by using combined psychological and neurobiological methods. I’m hoping to contribute to a better understanding of the mechanisms involved in insufficiently explained symptoms and to help patients suffering from these symptoms to recover.
Education
Master Neuropsychology, Utrecht University, the Netherlands, 2017
Bachelor Psychology, Erasmus University Rotterdam, the Netherlands, 2016
Guest employee
- Social & Behavioural Sciences
- Psychology
- Health, Medical & Neuropsychology
- van Lennep Johan P. A. Meijer Simone Karacaoglu Merve Rippe Ralph Peerdeman Kaya J. van Middendorp Henriët Evers Andrea W. M. (2025), Do patients with fibromyalgia syndrome and healthy people differ in their opinions on placebo effects in routine medical care?, Pain Practice 25: e70000.
- Karacaoglu M., Meijer S., Peerdeman K.J., Dusseldorp E.M.L., Veldhuijzen D.S., Middendorp H. van & Evers A.W.M. (2023), Susceptibility to nocebo hyperalgesia, dispositional optimism, and trait anxiety as predictors of nocebo hyperalgesia reduction, Clinical Journal of Pain 39(6): 259-269.
- Karacaoglu M., Peerdeman K.J., Numans M.E., Stolk M.R., Meijer S., Klinger R., Veldhuijzen D.S., Middendorp H. van & Evers A.W.M. (2023), Nocebo hyperalgesia in patients with fibromyalgia and healthy controls: an experimental investigation of conditioning and extinction processes at baseline and 1-month follow-up, The Journal of Pain 24(9): 1696-1711.
- Meijer S., Karacaoglu M., Middendorp H. van, Veldhuijzen D.S., Jensen K.B., Peerdeman K.J. & Evers A.W.M. (2023), Efficacy of open‐label counterconditioning for reducing nocebo effects on pressure pain, European Journal of Pain 27(7): 831-847.
- Meijer S., van Middendorp H., Peerdeman K.J. & Evers A.W.M. (2022), Counterconditioning as Treatment to Reduce Nocebo Effects in Persistent Physical Symptoms: Treatment Protocol and Study Design, Frontiers in Psychology 13: 806409.